Litigation Details for Genentech, Inc. v. Apotex Inc. (D. Del. 2019)
✉ Email this page to a colleague
Genentech, Inc. v. Apotex Inc. (D. Del. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-01-22 |
| Court | District Court, D. Delaware | Date Terminated | 2021-10-29 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 7,566,729; 7,635,707; 7,767,700; 7,816,383; 7,910,610; 8,013,002; 8,084,475; 8,318,780; 8,383,150; 8,420,674; 8,592,462; 8,609,701; 8,648,098; 8,754,109; 8,778,947; 9,561,217 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Genentech, Inc. v. Apotex Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Genentech, Inc. v. Apotex Inc. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-01-21 | 1 | U.S. Patent No. 7,566,729 25. U.S. Patent No. 7,566,729 (“the ‘729 patent”), entitled… U.S. Patent No. 7,767,700 29. U.S. Patent No. 7,767,700 (“the ‘700 patent”), entitled… U.S. Patent No. 8,013,002 35. U.S. Patent No. 8,013,002 (“the ‘002 patent”), entitled… U.S. Patent No. 8,383,150 41. U.S. Patent No. 8,383,150 (“the ‘150 patent”), entitled… U.S. Patent No. 8,609,701 47. U.S. Patent No. 8,609,701 (“the ‘701 patent”), entitled | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
